The authors declare that they have no conflict of interest.
References
Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011; 475:
91-5.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Tréziny C, Verrier L, et al.
Responder and nonresponder patients exhibit different peripheral transcriptional
signatures during major depressive episode. Transl Psychiatry 2012;2:e185.
Breitenstein B, Scheuer S, Holsboer F. Are there meaningful biomarkers of treatment
response for depression? Drug Discov Today 2014;19:539-61.
Clark SL, Adkins DE, Aberg K, Hettema JM, McClay JL, Souza RP, et al.
Pharmacogenomic study of side-effects for antidepressant treatment options in
STAR*D. Psychol Med 2012;42:1151-62.
Dwivedi Y. Emerging role of microRNAs in major depressive disorder: diagnosis and
therapeutic implications. Dialogues Clin Neurosci 2014;16:43-61.
Fass DM, Schroeder FA, Perlis RH, Haggarty SJ. Epigenetic mechanisms in mood disorders: targeting neuroplasticity. Neuroscience 2014; 264:112-30.
Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential
of gene coexpression networks for investigating molecular mechanisms of complex
brain disorders. Genes Brain Behav 2014;13:13-24.
Garbett KA, Vereczkei A, Kálmán S, Brown JA, Taylor WD, Faludi G, et al. Coordinated Messenger RNA/MicroRNA Changes in Fibroblasts of Patients with Major Depression.
Biol Psychiatry 2014 Jun 2. [Epub ahead of print]
Guilloux JP, Bassi S, Ding Y, Walsh C, Turecki G, Tseng G, et al. Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment
for major depression. Neuropsychopharmacology 2015;40:701-10.
Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, et al.
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of
female subjects with major depression. Mol Psychiatry 2012;17:1130-42.
Guo L, Zhao Y, Yang S, Zhang H, Chen F. An integrated analysis of miRNA, lncRNA, and
mRNA expression profiles. Biomed Res Int 2014;2014:345605.
Hepgul N, Cattaneo A, Zunszain PA, Pariante CM. Depression pathogenesis and treatment:
what can we learn from blood mRNA expression? BMC Med 2013;11:28.
Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, et al. Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol Psychiatry 2013; 74:734-41.
Kim SJ, Zhang Z, Sarkar C, Tsai PC, Lee YC, Dye L, et al. Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to
neuropathology in humans and mice. J Clin Invest 2008;118:3075-86.
Kishi T, Kitajima T, Tsunoka T, Okumura T, Ikeda M, Okochi T, et al. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese
population. Neuromolecular Med 2009;11:114-22.
Krystal JH, Sanacora G, Duman RS. Rapid-acting glutamatergic antidepressants: the path
to ketamine and beyond. Biol Psychiatry 2013; 73:1133-41.
Labermaier C, Masana M, Müller MB. Biomarkers predicting antidepressant treatment
response: how can we advance the field? Dis Markers 2013;35:23-31.
Lin E. Novel drug therapies and diagnostics for personalized medicine and nanomedicine in genome science, nanoscience, and molecular engineering. Pharmaceutical Regulatory
Affairs: Open Access 2012; 1:e116.
Lin E, Chen PS. Pharmacogenomics with antidepressants in the STAR*D study.
Pharmacogenomics 2008; 9:935-46.
Lin E, Hwang Y, Liang KH, Chen EY. Pattern-recognition techniques with haplotype analysis in pharmacogenomics. Pharmacogenomics 2007; 8:75-83.
Lin E, Hwang Y, Wang SC, Gu ZJ, Chen EY. An artificial neural network approach to the
drug efficacy of interferon treatments. Pharmacogenomics 2006; 7:1017-1024.
Lin E, Hsu SY. A Bayesian approach to gene-gene and gene-environment interactions in
chronic fatigue syndrome. Pharmacogenomics 2009; 10:35-42.
Lin E, Tsai SJ. Gene-gene interactions in a context of individual variability in antipsychotic
drug pharmacogenomics. Curr. Pharmacogenomics Person Med 2011; 9:323-331.
Lin E, Tsai SJ. Novel diagnostics R&D for public health and personalized medicine in Taiwan: current state, challenges and opportunities. Curr Pharmacogenomics Person
Med 2012; 10:239-246.
Liu Z, Li X, Sun N, Xu Y, Meng Y, Yang C, et al. Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive
disorder. PLoS One 2014;9:e93388.
Mamdani F, Berlim MT, Beaulieu MM, Labbe A, Merette C, Turecki G. Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Transl
Psychiatry 2011;1:e13.
Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 2007;10:19-26.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to
2030. PLoS Med 2006; 3:e442.
Mehta D, Menke A, Binder EB. Gene expression studies in major depression. Curr
Psychiatry Rep 2010;12:135-44.
Menke A. Gene expression: biomarker of antidepressant therapy? Int Rev Psychiatry
2013;25:579-91.
Menke A, Binder EB. Epigenetic alterations in depression and antidepressant treatment.
Dialogues Clin Neurosci 2014; 16:395-404.
Morag A, Pasmanik-Chor M, Oron-Karni V, Rehavi M, Stingl JC, Gurwitz D. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a
putative SSRI antidepressant response biomarker. Pharmacogenomics 2011;12:171-84.
Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell
2011;145:178-81.
Ng SY, Lin L, Soh BS, Stanton LW. Long noncoding RNAs in development and disease of
the central nervous system. Trends Genet 2013;29:461-8.
Novianti PW, Roes KC, Eijkemans MJ. Evaluation of gene expression classification
studies: factors associated with classification performance. PLoS One 2014;9:e96063.
Oved K, Morag A, Pasmanik-Chor M, Oron-Karni V, Shomron N, Rehavi M, et al.
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines
identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics
2012;13:1129-39.
Oved K, Morag A, Pasmanik-Chor M, Rehavi M, Shomron N, Gurwitz D. Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in
the mode of action of antidepressants. Transl Psychiatry 2013;3:e313.
Rezola A, Pey J, Tobalina L, Rubio A, Beasley JE, Planes FJ. Advances in network-based metabolic pathway analysis and gene expression data integration. Brief Bioinform 2014
Mar 13. [Epub ahead of print]
Seifuddin F, Pirooznia M, Judy JT, Goes FS, Potash JB, Zandi PP. Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry
2013;13:213.
Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, et al.
Patterns of gene expression in the limbic system of suicides with and without major
depression. Mol Psychiatry 2007;12:640-55.
Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr, et al.
Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006;63:35-48.
Serretti A, Kato M, Kennedy JL. Pharmacogenetic studies in depression: a proposal for
methodologic guidelines. Pharmacogenomics J 2008; 8:90-100.
Shukla GC, Singh J, Barik S. MicroRNAs: Processing, Maturation, Target Recognition and
Regulatory Functions. Mol Cell Pharmacol 2011;3:83-92.
Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, Zitman FG, et al.
Stimulated gene expression profiles as a blood marker of major depressive disorder.
Biol Psychiatry 2010;68:179-86.
Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood
and brain. Am J Med Genet B Neuropsychiatr Genet 2006;141B:261-8.
Ulrich-Merzenich G, Kelber O, Koptina A, Freischmidt A, Heilmann J, Müller J, et al.
Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine. Phytomedicine
2012;19:930-9.
Verma R, Mukerji M, Grover D, B-Rao C, Das SK, Kubendran S, et al. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India. Biol Psychiatry
2005;58:16-22.
Watanabe RM. Statistical issues in gene association studies. Methods Mol Biol 2011;700:17-36.
Wheeler HE, Dolan ME. Lymphoblastoid cell lines in pharmacogenomic discovery and
clinical translation. Pharmacogenomics 2012;13:55-70.
Whyte A, Jessen T, Varney S, Carneiro AM. Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain. Neurochem Int 2014;73:122-6.